Clinical Trial Update: A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Synvisc to Depo-Medrol for osteoarthritis of the hip has been completed, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip

Drugs mentioned

• DEPO-MEDROL (Methylprednisolone acetate)
• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Osteoarthritis, Hip, Musculoskeletal Diseases | Phase 3 | Status: COMPLETED